MedPath

TEVA-ANASTROZOLE

TEVA-ANASTROZOLE

Discontinued
DIN Number

02313049

Drug Class

Human

Market Date

Oct 25, 2012

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02313049
AIG Number0128681001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BG03 ANASTROZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ANASTROZOLEActive
Strength: 1 MG
Monograph: ANASTROZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.